Resveratrol, a constituent of grapes and other foods, has been reported to be a potential cancer chemopreventive agent. Our previous study showed that the antitumor activity of resveratrol occurs through mitogen-activated protein kinases-mediated p53 activation and induction of apoptosis. To develop more effective agents with fewer side effects for the chemoprevention of cancer, we investigated the effect of resveratrol and its structurally related derivatives on epidermal growth factor (EGF)-induced cell transformation. Our results provided the first evidence that one of the resveratrol derivatives exerted a more potent inhibitory effect than resveratrol on EGFinduced cell transformation, but had less cytotoxic effects on normal nontransformed cells. Compared to resveratrol, this compound also caused cell cycle arrest in the G1 phase, but did not induce p53 activation and apoptosis. Furthermore, this compound, but not resveratrol, markedly inhibited EGF-induced phosphatidylinositol-3 kinase (PI-3K) and Akt activation. Collectively, these data suggested that the higher antitumor effect of the compound compared to resveratrol, may act through a different mechanism by mainly targeting PI-3K/Akt signaling pathways.
Introduction
Chemoprevention, which is recognized as the pharmacological intervention with synthetic or naturally occurring agents to prevent, inhibit or reverse carcinogenesis or prevent the development of invasive cancer, has become increasingly appreciated as a new strategy in the fight against cancer (Hong and Sporn, 1997; Kelloff et al., 2000; Sporn and Suh, 2000) . In recent years, many naturally occurring compounds, commonly present in the diet and in beverages consumed by the human population, have gained considerable attention as chemopreventive agents (Hong and Sporn, 1997; Kelloff et al., 2000; Sporn and Suh, 2000) . In this regard, resveratrol (3, 5, 4 0 -trihydroxy-trans-stilbene) (Figure 1 ), a phytoalexin found in a multitude of dietary plants including grapes and peanuts, has been shown to provide cancer chemopreventive effects in different systems based on its striking inhibition of diverse cellular events associated with tumor initiation, promotion and progression (Jang et al., 1997) . This is partly attributable to its antioxidant activities and its inhibition of cyclooxygenase 1 and 2 (Jang et al., 1997; Subbaramaiah et al., 1998 ). An accumulation of evidence has further shown that the anticancer properties of resveratrol are related to its ability to downregulate activation of NFkB (Tsai et al., 1999) , cause cell cycle arrest in the G1 phase (Hsieh and Wu, 1999; Adhami et al., 2001; Ahmad et al., 2001) or in the S-G2 phase transition (Ragione et al., 1998) , or to trigger apoptosis in a variety of cancer cell lines (Clement et al., 1998; Hsieh and Wu, 1999; Surh et al., 1999; Park et al., 2001) . Recently, we offered a possible molecular mechanism by which the antitumor activity of resveratrol was shown to occur through mitogen-activated protein kinases-mediated p53 activation and subsequent induction of apoptosis (Huang et al., 1999b; She et al., 2001 She et al., , 2002 . To better understand the mechanistic basis for the chemopreventive properties of resveratrol and develop more effective agents for the prevention of cancer, we synthesized two resveratrol derivatives designated as 3,5,3 0 ,4 0 -tetrahydroxy-trans-stilbene (RSVL-1) and 3,5,3 0 ,4 0 ,5 0 -pentahydroxy-trans-stilbene (RSVL-2) (Figure 1 ). We used a mouse JB6 epidermal cell line, a well-developed cell culture model for studying tumor promotion (Bernstein and Colburn, 1989; Dong et al., 1994; Huang et al., 1996 Huang et al., , 1999a , to investigate the relation of structure and antitumor activity of resveratrol and its derivatives. Furthermore, we studied the molecular mechanisms involved in their chemopreventive effect on cancer.
Results and discussion

RSVL-2 exhibits a potent inhibitory effect on epidermal growth factor (EGF)-induced cell transformation
Previous studies examining the chemopreventive effects of resveratrol focused mainly on 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-induced tumor promotion (Jang et al., 1997; Subbaramaiah et al., 1998) . In particular, investigators showed recently that resveratrol inhibited TPA-induced mouse skin tumor promotion (Jang et al., 1997) and TPA-mediated activation of protein kinase C and cyclooxygenase 1 and 2 in human mammary epithelial cells (Subbaramaiah et al., 1998) . EGF has been known to induce cell transformation in JB6 Cl 41 cells (Huang et al., 1996) . To our knowledge, much less is known about the effects of resveratrol and its derivatives on EGF-induced cell transformation.
To investigate the molecular basis for the antitumor promotion effect of resveratrol and its derivatives, we used the JB6 Cl 41 cell culture model (Bernstein and Colburn, 1989; Dong et al., 1994; Huang et al., 1996; 1999a, b) for studying the antitumor promotion effects. As reported previously (Huang et al., 1996) , EGF induces transformed colonies in soft agar at high frequency, and in this study, we found that resveratrol inhibited EGF-induced cell transformation in JB6 cells in a concentration-dependent manner (Figure 2 ). The concentration range for effective inhibition was from 5 to 40 mm. Compared with the antitumor activity of resveratrol, the structural analogue, RSVL-2, exhibited a more potent inhibitory effect on EGF-induced cell transformation in the same concentration range (Figure 2 ). Lower concentrations, especially 10 mm RSVL-2, were more effective than resveratrol in inhibiting cell transformation (Po0.008), and cell transformation was almost completely blocked at 20 mm RSVL-2. In contrast, another structural analogue, RSVL-1, had no significant effect at 5-10 mm, and showed a lower inhibition of cell transformation at the concentration range of 20-40 mm compared to resveratrol (Po0.03) (Figure 2 ). In addition, we also found that RSVL-2 exerted a markedly higher inhibition than resveratrol on TPA-induced cell transformation (data not shown). These results suggested that the presence of all three hydroxyl groups on the B ring in the structure of RSVL-2 (Figure 1 ) may be important for its greater inhibitory activity against cell transformation. ) were exposed simultaneously to 20 ng/ml of EGF with or without different concentrations of RSVL, RSVL-1 or RSVL-2 in 0.33% BME agar containing 10% FBS over 3.5 ml of 0.5% BME agar containing 10% FBS. Cell colonies were scored after 14 days of incubation at 371C in 5% CO 2 . Results are expressed as the mean 7s.e. of three independent experiments. *Po 0.03, RSVL-1 (20-40 mm) vs RSVL (20-40 mm); **P o 0.008, RSVL-2 (10-40 mm) vs RSVL (10-40 mm)
RSVL-1 and RSVL-2 have no redundant cytotoxic effects on normal nontransformed cells Resveratrol has been shown to induce cell death in many cancer cell types (Clement et al., 1998; Hsieh and Wu, 1999; Surh et al., 1999; Ahmad et al., 2001) . Ideally, for an effective chemopreventive strategy, the agent should be able to impart apoptotic/antiproliferative effects specifically in cancer cells without affecting normal cells. Little is known about the cytotoxic effect of resveratrol on normal nontransformed cells. JB6 mouse epidermal cells, when not exposed to TPA, EGF or other carcinogens, are normal cells. Therefore, we used JB6 cells to evaluate the effects of resveratrol and its derivatives on cell growth by the MTT assay. Results showed that RSVL-1 and RSVL-2 did not result in any inhibition of cell growth at the concentration range of 5-10 mm even 5 days after treatment (Figure 3 ). High concentrations (20-40 mm) of RSVL-1 or RSVL-2 had some inhibitory effects on cell growth. In contrast, resveratrol markedly inhibited JB6 cell growth in a concentration-dependent manner even 1 day after treatment. The lower cytotoxic effects of RSVL-1 and RSVL-2 on JB6 cells may be attributable to their increased number of hydroxyl group, which has been suggested to contribute to a higher antioxidant activity compared to resveratrol (Wang et al., 1999) . Therefore, these results, taken together with the above results, indicated that RSVL-2 specifically and markedly inhibits the growth of transformed cells with less cytotoxic effects on normal nontransformed cells.
Resveratrol treatment results in G1 phase arrest
To assess whether the differential effects of resveratrol and its derivatives on growth inhibition of JB6 cells is mediated via alterations in cell cycle regulation, we evaluated the effect of resveratrol and its derivatives on cell cycle distribution. Analysis by flow cytometry showed that treatment with 20 mm resveratrol or its derivatives in the absence of EGF or fetal bovine serum (FBS) caused no remarkable changes in cell cycle distribution (Figure 4) . In response to EGF stimulation, however, resveratrol markedly resulted in growth arrest and an accumulation of cells in G1 phase as well as a loss of cells in S phase, indicating that resveratrol induces G1 arrest (Figure 4 ). Compared to resveratrol, RSVL-2 showed a lesser effect on G1 arrest after EGF stimulation. In contrast, RSVL-1 did not cause G1 arrest. In the presence of 5% FBS, resveratrol also resulted in a greater G1 arrest than RSVL-1 or RSVL-2 (Figure 4) . These results suggested that the higher cell cycle cytotoxic effects of resveratrol may be in part mediated through its higher capacity to cause cell cycle dysregulation.
Resveratrol, but not RSVL-1 or RSVL-2, induces p53 activation and apoptosis
The p53 tumor suppressor protein is a potent transcription factor that enhances the transcriptional rate of several known genes that play a critical role in the process of apoptosis and the cell's defense against tumor development (Levine, 1997; Prives and Hall, 1999) . Our previous studies have demonstrated that the chemopreventive activity of resveratrol is related to its ability to induce p53 activation and apoptosis (Huang et al., 1999b; She et al., 2001 She et al., , 2002 . To investigate whether the molecular mechanisms of the antitumor promotion actions of resveratrol derivatives also involve the induction of p53 activation, JB6 Cl 41 cells stably expressing a luciferase reporter gene controlled by p53 Figure 3 Effect of resveratrol and its derivatives on cell growth. JB6 Cl 41 cells were treated with different concentrations of resveratrol, its derivatives or their vehicle, DMSO (o 0.1%), as a negative control in 5% FBS MEM for the indicated times. The viability of cells was determined by the MTT assay as described in Materials and methods. Results are expressed as relative cell viability (% of control) and represent the mean 7s.e. of two independent experiments in which each treatment was performed in four wells. *P o 0.03, resveratrol or its derivatives vs control DNA binding sequences (el-Deiry et al., 1992; Huang et al., 1997b) were used. Results indicated that p53-dependent transcription activity was markedly induced by resveratrol in a dose-dependent manner at the concentration range of 5-20 mm as shown previously (Huang et al., 1999b; She et al., 2001) , and treatment with RSVL-1 resulted in a slight induction of p53 activation at the concentration range of 10-20 mm (Figure 5a ). In contrast, RSVL-2 did not induce p53-dependent transcription activity. Furthermore, we assessed DNA fragmentation as an indication of apoptosis and found that fragmentation occurred with 10 or 20 mm (data not shown) resveratrol, but was not observed with RSVL-1 or RSVL-2 (Figure 5b ). In addition, flow cytometry analysis further confirmed that resveratrol, but not its derivatives, induced apoptosis (Figure 5c ). These results indicated that the inhibitory effect of RSVL-1 or RSVL-2 on cell transformation does not occur through p53-mediated apoptosis, suggesting that other mechanisms must be involved.
RSVL-2 blocks EGF-induced PI-3K and Akt activation
PI-3K is a ubiquitously expressed enzyme that, through the generation of phospholipid messengers, plays a critical role in the regulation of many cellular processes including cell transformation (Huang et al., 1996 (Huang et al., , 1997a Dong et al., 1999; Stein and Waterfield, 2000) . Evidence that PI-3K plays a role in cell transformation was obtained from studies using PI-3K inhibitors and dominant-negative PI-3K p85 subunit (P85), as well as mutated tyrosine kinases of growth factor receptor (Kaplan et al., 1987; Coughlin et al., 1989; Serunian et al., 1990; Huang et al., 1996) . Our previous studies demonstrated that inactivation of PI-3K by using PI-3K inhibitors (wortmannin or LY294002) or introducing DP85, a dominant-negative PI-3K, completely blocks EGF-induced transformation in JB6 cells (Huang et al., 1996) . Thus, PI-3K was assumed to serve as a significant target for the development of new antitumor drugs or chemopreventive agents (Dong et al., 1999; Stein and Waterfield, 2000) . To test whether PI-3K is a target for resveratrol and its derivatives, we assessed EGF-induced PI-3K activation after pretreatment with resveratrol or its derivatives. Since a low concentration of RSVL-2 was effective in inhibiting cell transformation with less cytotoxicity, we used 10 mm resveratrol or its derivatives in this experiment. The results showed that RSVL-2 profoundly inhibited EGF-induced PI-3K activation in JB6 cells (Figure 6a ). On the other hand, resveratrol or RSVL-1 had no significant effect on EGF-induced PI-3K activation (P>0.05), although resveratrol tended to decrease EGF-induced PI-3K activity. Furthermore, we tested whether RSVL-2 is a direct inhibitor of PI-3K in vitro. We found that RSVL-2 could directly block PI-3 kinase activity in an in vitro kinase assay (data not shown), suggesting that PI-3K is the direct target of RSVL-2 for its antitumor promotion activity. The proto-oncogene serine/threonine kinase, Akt, is a wellknown effector of PI-3K. Using antibodies against the phosphorylated (activated) Akt and Western blotting, we found that RSVL-2, but not resveratrol or RSVL-1, also substantially inhibited EGF-induced Akt activation (Figure 6b ). These results suggested that the presence of three hydroxyl groups on the B ring in the structure of RSVL-2 may facilitate its interaction with PI-3K and target its activity and downstream kinase, Akt. The wellknown functions of Akt in modulating cyclin D1, p21, or p27 levels or their cellular distribution, inducing angiogenesis or inhibiting tumor cell apoptosis (Diehl et al., 1998; Datta et al., 1999; Collado et for its importance in tumor development. The careful analysis of these aspects in the further study will help to define clearer molecular mechanisms responsible for the antitumor effect of RSVL-2. In summary (Table 1) , comparisons of the biological activities of resveratrol and its derivatives suggest the importance of the presence of the three hydroxyl groups on the B ring in the structure of RSVL-2 in its antitumor activities and cytotoxicity. Whether all three hydroxyl groups is required or a hydroxyl group at positions 3 0 and 5 0 or position 5 0 only is sufficient for the antitumor activities of RSVL-2 is currently being investigated. Our results in this study provide the first evidence that the resveratrol structural analogue, RSVL-2, is a more effective and less toxic agent for the inhibition of cell transformation. Compared with the mechanism of action of resveratrol, RSVL-2 appears to act differently by mainly targeting the PI-3K/Akt Potent antitumor activity by a resveratrol derivative Q-B She et al signaling pathway for its antitumor effect. Practically speaking, understanding the molecular mechanistic basis for the chemopreventive properties of resveratrol and its derivatives may be helpful in designing more effective agents with fewer side effects for the chemoprevention or treatment of cancer.
Materials and methods
Materials
Resveratrol (99% purity) and MTT were purchased from Sigma (St Louis, MO, USA). RSVL-1 and RSVL-2 were synthesized and purified through column chromatography and more than 98% purity verified by HPLC and TLC (Wang et al., 1999) . Dimethyl sulfoxide (DMSO) was from Pierce (Rockville, IL, USA). EGF was from Collaborative Research (Bedford, MA, USA). Agarose conjugated with polyclonal PI-3 kinase p85a antibody was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Phospho-specific Akt (Ser473) and Akt antibodies were from Cell Signaling Inc. (Beverly, MA, USA). Eagle's minimal essential medium (MEM) was from Life Technologies, Inc. (Grand Island, NY, USA); FBS was from BioWhittaker, Inc. (Walkersville, MD, USA) and luciferase substrate was from Promega (Madison, WI, USA).
Anchorage-independent transformation assay
The effect of resveratrol and its derivatives on EGF-induced cell transformation was investigated. JB6 Cl 41 cells (1 Â 10 4 ) were exposed to EGF (20 ng/ml) with or without resveratrol or its derivatives in 1 ml of 0.33% basal medium Eagle (BME) agar containing 10% FBS over 3.5 ml of 0.5% BME agar containing 10% FBS. The cultures were maintained in a 371C, 5% CO 2 incubator for 14 days, and the cell colonies were scored as described previously (Dong et al., 1994; Huang et al., 1996 Huang et al., , 1999a .
Cell proliferation assay
JB6 Cl 41 cells were seeded into a 96-well plate at 5 Â 10 3 cells per well. The cells were treated for the indicated times with different concentrations of resveratrol, its derivatives or their vehicle, DMSO (o0.1%), which was used as a negative control. The relative changes in the number of viable cells were determined by the MTT assay as described previously (She et al., 2000) , and a Labsystem Multiskan MS microplate reader was used to read the absorbance of formazan at a wavelength of 540 nm (She et al., 2000) .
Assay for p53-dependent transcriptional activity
A PG13-luciferase reporter gene, which is a typical p53-binding-site reporter construct (el-Deiry et al., 1992) , was stably transfected in mouse epidermal JB6 Cl 41 cells (Huang et al., 1997b) . Confluent monolayers of the stable p53 luciferase reporter transfectant cells were trypsinized and 1 Â 10 4 viable cells suspended in 100 ml of 5% FBS MEM were seeded into each well of a 96-well plate. Plates were incubated Figure 6 Blocking of EGF-induced PI-3K and Akt activities by RSVL-2. (a) JB6 Cl 41 cells were either pretreated or not pretreated with 10 mm resveratrol, its derivatives or 200 nm wortmannin, an inhibitor of PI-3K, for 20 min, followed by treatment with EGF (20 ng/ml) for 30 min. The cells were harvested, and PI-3 kinase activity was measured and quantified as described in Materials and methods. Results are expressed as relative PI-3K activity compared to the untreated control and represent the mean 7s.e. of two independent experiments. *Po0.005, RSVL-2 or wortmannin vs control. (b) JB6 Cl 41 cells were either pretreated or not pretreated with 10 mm resveratrol or its derivatives for 20 min, followed by treatment with EGF (20 ng/ml) for 30 and 60 min. The cells were then extracted and levels of phosphorylated and total Akt proteins detected by Western blotting with phospho-specific or nonphospho-Akt antibodies , which was used as a negative control, for 24 h. Cells were then harvested and extracted, and luciferase activity was measured using a luminometer (Monolight, 2010) as described previously (She et al., 2001) .
DNA fragmentation assay
JB6 Cl 41 cells were grown in a 10 cm dish and when cell density reached 80-90% confluence, cells were treated with 10 mm resveratrol or its derivatives for 16 h. Both detached and attached cells were harvested by scraping and centrifugation. The cells were then disrupted with lysis buffer (5 mm Tris, pH 8.0, 20 mm EDTA and 0.5% Triton X-100) on ice for 45 min. After centrifugation at 14 000 r.p.m. for 45 min at 41C, the supernatant fraction that contained fragmented DNA was saved, while genomic DNA was excluded in the pellet. The fragmented DNA was extracted from the supernatant fraction, which contained 1 mg of protein, twice with phenol : chloroform : isoamyl alcohol (25 : 24 : 1, v/v) and once with chloroform and then precipitated overnight at À201C with ethanol and 5 m NaCl. The DNA pellet was washed once with 70% ethanol and resuspended in Tris-EDTA buffer (pH 8.0) with 100 mg/ml RNase and incubated at 371C for 2 h. The DNA fragments were separated by 1.8% agarose gel electrophoresis and visualized under UV light (She et al., 2001) .
Flow cytometry analysis of cell cycle and apoptosis JB6 cells were grown in 5% FBS/MEM in a 60 mm dish and when cell density reached 80-90% confluence, cells were starved for 24 h in 0.1% FBS/MEM. They were then treated or not treated with 10-20 mm resveratrol in 0.1% FBS/MEM for 52 h and harvested in 70% ethanol overnight and stained with propidium iodide for the analysis of cell cycle and apoptosis.
PI-3 kinase assay
A PI-3 kinase activity assay was carried out as described previously (Huang et al., 1996) . In brief, JB6 Cl 41 cells were either treated or not treated with 10 mm resveratrol or its derivatives for 20 min, followed by treatment with EGF (20 ng/ ml) for 30 min. The cells were harvested, and PI-3 kinase was immunoprecipitated with a polyclonal PI-3 kinase p85a antibody. Then, the PI-3 kinase activity was measured in the presence of 250 mm ATP containing 10 mCi of [g-32 P]ATP using phosphatidylinositol as substrate. The product, PI-3 phosphate, was separated by TLC and the radiolabeled spots were quantified using the Storm 840 Phospho-Imager (Molecular Dynamics, Sunnyvale, CA, USA).
Western blotting
Immunoblotting for phosphorylated and total proteins of Akt was carried out by using phospho-specific or nonphosphoantibodies as described previously (She et al., 2001) . Antibodybound proteins were detected by chemifluorescence and analysed with the Storm 840 Phospho-Imager System.
Statistics
For comparison between resveratrol and its derivatives, Student's t-test was used to determine significant differences. P-value o0.05 was considered to be significant.
